Capricor Therapeutics
CompanyUnited StatesFounded 2007
Capricor Therapeutics develops one asset, in phase 3 (deramiocel in Duchenne muscular dystrophy). Mostly cell therapy; based in the United States, founded in 2007.
- 1
- Asset
- Furthest stage
- Phase 3
- 0
- Trials
- 0
- Signals
Pipeline
1Allogeneic cardiosphere-derived cell therapy for Duchenne muscular dystrophy
Phase 3, Cell therapy, Duchenne muscular dystrophy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies3